Active	Status	Sponsor type	Region	Phase	Filter
4 Active 0 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Lee, Matthew KC
SGNTUC 024, NCT04430738: Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers	Active, not recruiting	1/2	41	Japan, US	tucatinib, TUKYSA, trastuzumab, oxaliplatin, leucovorin, fluorouracil, capecitabine, pembrolizumab, KEYTRUDA	Seagen Inc.	Colorectal Carcinoma, Gastric Adenocarcinoma, GEJ Adenocarcinoma, Esophageal Adenocarcinoma, Cholangiocarcinoma, Gallbladder Carcinoma	07/24	10/25
MASH, NCT04197271: Management of Acutely Symptomatic Hernia	Active, not recruiting	N/A	280	Europe	Emergency Hernia Repair, Conservative management, Non-operative management	Sheffield Teaching Hospitals NHS Foundation Trust	Hernia, Emergencies, Surgery--Complications	11/20	03/21
AFAR, NCT04037319: Atrial Fibrillation After Surgery for Colorectal Cancer	Recruiting	N/A	720	Europe	24 Hour Holter Monitor	Sheffield Teaching Hospitals NHS Foundation Trust	Colorectal Cancer, Atrial Fibrillation New Onset	12/23	03/24
PRO-diGI, NCT05315765: Development of a Patient Reported Outcome Measure for GastroIntestinal Recovery	Recruiting	N/A	560	Europe		Sheffield Teaching Hospitals NHS Foundation Trust, University of Sheffield	Ileus, Small Bowel Obstruction, Intestinal Failure	01/23	03/23
Freas, Elizabeth
No trials found